LLY

$777.96

▼-0.03%

wb_incandescent Backtest

Stock

Eli Lilly and Company Common Stock

Official Company Name: Eli Lilly and Company

Stock Symbol: LLY

Stock Market: New York Stock Exchange - NYSE

Currency: United States dollar - USD

business Lilly Company Profile

LLY Stock Price - 1 Year Price Evolution & Moving Averages

1 Year Return

▲+131.63%

file_download

Daily closing prices, with moving averages and volumes - United States dollar (USD)
Moving averages:

  • EMA20
  • SMA50
  • SMA200

Company Description

Eli Lilly and Company, more simply known as Eli Lilly or just Lilly, is a pharmaceutical company. Founded in 1876, Eli Lilly is engaged in the research, development, manufacturing, and marketing of insulin and endocrinology products for diabetes, psychiatric medication including Prozac, as well as treatments for osteoporosis, human growth hormone deficiency, pediatric growth conditions, autoimmune diseases, and diverse types of cancers.

business Lilly Company Profile

LLY Stock Data

Open $780.32
High $793.67
Low $776.44
Close $777.96
Volume 3,185,015
Previous Close $778.18
1-Day Change -0.22
1-Year Change 442.09
Average Daily Volume 3,063,373
52-Week High $792.28
52-Week Low $335.87

LLY Stock References

warning

Disclaimer

All information and data available on Disfold is NOT FINANCIAL ADVICE. Invest at your own risk!

Past performance is not a guarantee of future performance. Patterns tend to repeat themselves, but they don't necessarily have to.

Successful backtests on past data do not guarantee the future success of the strategy backtested, especially as backtest overfitting may occur: when the price of a stock may fit particularly well a given trading strategy over a given period, but not necessarily outside of that period. Besides, backtests do not account for exact market conditions and may yield significantly different results in real trading practice (fees, slippage...).

Furthermore, even though Disfold strives to provide the best and most accurate data, errors can occur in Disfold's systems, or in our data providers' systems.

Please conduct your own due diligence to verify insights.